Outcomes in patients with systemic sclerosis undergoing early vs delayed intervention with potential disease-modifying therapies.
Keina YomonoMasataka KuwanaPublished in: Rheumatology (Oxford, England) (2022)
A therapeutic 'window of opportunity' might exist in SSc patients.
Keyphrases
- systemic sclerosis
- interstitial lung disease
- end stage renal disease
- randomized controlled trial
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- type diabetes
- metabolic syndrome
- rheumatoid arthritis
- adipose tissue
- risk assessment
- skeletal muscle
- insulin resistance
- patient reported outcomes
- human health
- idiopathic pulmonary fibrosis